A PMHNP has a close friendship with a pharmaceutical representative who promotes a medication for schizophrenia. The PMHNP does prescribe the medication her friend sells, but not more often than any other drug for schizophrenia. Her friend does not offer any type of incentive to the PMHNP to incentivize her to write more prescriptions. Would this be considered a conflict of interest?

Choice A reason: While the PMHNP may not have a formal relationship with the company, her close friendship with a representative creates a potential for bias. Personal relationships can influence prescribing behavior, even unconsciously. Choice B reason: Disclosure to patients is not typically required unless there is a direct financial relationship or incentive. However, the ethical concern lies in the potential for bias, not necessarily the need for patient disclosure in this context. Choice C reason: This is the most accurate answer. A close friendship with a pharmaceutical representative can create a conflict of interest, even if no incentives are offered. The emotional connection may unconsciously influence prescribing decisions, which raises ethical concerns about impartiality. Choice D reason: While indirect financial gain is possible, the core issue is the influence of personal relationships on professional decisions. Gifts may contribute to bias, but the friendship itself is the primary concern.